An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
After publication and correction of this article [1, 2], concerns were raised about Figs 2B, 7E and 9A and S4. Specifically:
In Fig 2B, when levels are adjusted to visualize the background, there appear to be vertical discontinuities between lanes 1 and 2 in both the E-3 and merge panels.
In Fig 7E, there appears to be a vertical discontinuity in the background of the right 2A/2A110 panel, between lanes 14 and 15.
In Fig 9A, in the top panel, there appear to be vertical discontinuities in the background between lanes 1 and 2; lanes 5 and 6; lanes 7 and 8; and lanes 9 and10.
In S4 Fig, when levels are adjusted to visualize the background, there appear to be vertical discontinuities in some panels and the images are not annotated to demark different gels.
The first author provided corrected figures and the following explanations:
The molecular weight markers from repeat experiments were used in the E-3 and merge panels of Fig 2B. The corrected figure includes the marker lane from the same original blot as the experimental results shown in the figure.
For Fig 7B, lanes 1–8 and lanes 9–12 were combined from two blot images. The corrected Fig 7B has vertical lines to clearly indicate different image sources. For Fig 7E, when samples in the 2A/2A110 right panel were examined in SDS-PAGE, samples in lanes 15 and 16 were loaded in the reverse order. Lanes 15 and 16 were thus rearranged during figure preparation. In the corrected Fig 7E a vertical line indicates where the image was spliced.
The top panel in Fig 9A was the combination of two representative western blot images, and except for the m-MAVS-251 lanes the PABP and Actin data shown in the lower panels of the figure are from a different experiment than the data shown in the upper panel (see S1 File). The corrected figure shows the result from a single image with a vertical line to indicate where lanes were removed.
The results in S4 Fig were the combination of screening data aimed at identifying the 3Cpro cleavage sites in MAVS. The large number of screening samples was examined in multiple gels. The corrected figure has vertical lines to clearly indicate different image sources.
The raw data underlying the corrected figures are provided in S2 File. Raw data underlying other results in the article are in S3 File.
The authors apologize for the errors in the published article.
Note: Corresponding author Zhendong Zhao is deceased. Future inquiries about this article should be directed to the first author Bei Wang at wangbei20170217@163.com.
Supporting information
S4 Fig. Protease-Glo assay of 3Cpro activity on MAVS.
Data depicts the screening assay testing 3Cpro activity on 86 constructs containing the coding region for the 12-mer polypeptides covering the MAVS extra-membrane region. Luciferase assay results are shown together with gel analysis results.
1.Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, et al. (2013) Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses. PLoS Pathog
9(3): e1003231. 10.1371/journal.ppat.1003231
[DOI] [PMC free article] [PubMed] [Google Scholar]
2.Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, et al. (2017) Correction: Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses. PLoS Pathog
13(3): e1006243. 10.1371/journal.ppat.1006243
[DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
S4 Fig. Protease-Glo assay of 3Cpro activity on MAVS.
Data depicts the screening assay testing 3Cpro activity on 86 constructs containing the coding region for the 12-mer polypeptides covering the MAVS extra-membrane region. Luciferase assay results are shown together with gel analysis results.